Effects of shuanghuanglian injection on the activities of CYP1A2, 2C11, 2D1 and 3A1/2 in rats in vivo and in vitro

References

• Armani S, Ting L, Sauter N, et al. (2017). Drug interaction potential of osilodrostat (LCI699) based on its effect on the pharmacokinetics of probe drugs of cytochrome P450 enzymes in healthy adults. Clin Drug Investig 37:465–72.
   PubMed Web of Science ®Google Scholar
• Berger B, Bachmann F, Duthaler U, et al. (2018). Cytochrome P450 enzymes involved in metoprolol metabolism and use of metoprolol as a CYP2D6 phenotyping probe drug. Front Pharmacol 9:774.
   PubMed Web of Science ®Google Scholar
• Bjornsson TD, Callaghan JT, Einolf HJ, et al. (2003). The conduct of in vitro and in vivo drug-drug interaction studies: a pharmaceutical research and manufacturers of America (PhRMA) perspective. Drug Metab Dispos 31:815–32.
   PubMed Web of Science ®Google Scholar
• Brown CM, Reisfeld B, Mayeno AN. (2008). Cytochromes P450: a structure-based summary of biotransformations using representative substrates. Drug Metab Rev 40:1–100.
   PubMed Web of Science ®Google Scholar
• Chang HH. (2012). Clinical observation of shuanghuanglian powder injection combined dioctahedral smectite on 48 cases of rotavirus enteritis. Chin Pediatr Integr Tradit West Med 4:338–9.
   Google Scholar
• Chen CZ. (2012). Effect analysis of cefoperazone sodium and sulbactam sodium combined with Shuanghuanglian injection in the treatment of 80 infants with lower respiratory tract infection. Chin J Clin Ration Drug Use 5:46–7.
   Google Scholar
• Chen H, Mi SQ, Wang NS, et al. (2012). Study of renal toxicity of shuanghuanglian injectable powder combined with cefepime hydrochloride. Tradit Chin Drug Res Clin Pharmacol 23:125–8.
   Google Scholar
• Chen H, Min JB, Li W, et al. (2016). The pharmacokinetics change of cefepime after Shuanghuanglian injection administration in subjects with the renal damage. Drug Chem Toxicol 39:129–36.
   PubMed Web of Science ®Google Scholar
• Chen SY. (2011). Azithromycin combined shuanghuanglian powder injection sequential therapy 34 cases of community-acquired pneumonia. J Emerg Radition Chin Med 20:815.
   Google Scholar
• Chu V, Einolf HJ, Evers R, et al. (2009). In Vitro and in Vivo induction of cytochrome P450: a survey of the current practices and recommendations: a pharmaceutical research and manufacturers of America perspective. Drug Metab Dispos 37:1339–54.
   PubMed Web of Science ®Google Scholar
• Coon MJ. (2005). Cytochrome P450: nature's most versatile biological catalyst. Annu Rev Pharmacol Toxicol 45:1–25.
   PubMed Web of Science ®Google Scholar
• Dixit V, Hariparsad N, Desai P, et al. (2007). In vitro LC-MS cocktail assays to simultaneously determine human cytochrome P450 activities. Biopharm Drug Dispos 28:257–62.
   PubMed Web of Science ®Google Scholar
• Dong CL, Shen JL. (2010). Analysis of cefradine combined with shuanghuanglian injectable lead to one death. Med J Chin People's Health 22:25–6.
   Google Scholar
• Food and Drug Administration. (2016). Drug Development and Drug Interactions: Table of Substrates, Inhibitors and Inducers. Available from:https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ucm093664.htm.
   Google Scholar
• Gao CL, Miao MS. (2010). SHLI of pharmacological and clinical research and analysis. Lishizhen Med Mater Med Res 21:3066–70.
   Google Scholar
• Gao J, Shi Z, Zhu S, et al. (2013). Influences of processed rhubarbs on the activities of four CYP isozymes and the metabolism of saxagliptin in rats based on probe cocktail and pharmacokinetics approaches. J Ethnopharmacol 145:566–72.
   PubMed Web of Science ®Google Scholar
• Gao Z, Zhang Y, Zhou B. (2017). Clinical study on Zhuli capsules combined with Shuanghuanglian injection in treatment of acute and chronic pharyngitis. Drugs Clin 32:1247–50.
   Google Scholar
• Guo WY, Xing JY, Zhang QH. (2014). Clinical study on Shuanghuanglian injection combined with clindamycin phosphate injection in treatment of acute and chronic pharyngitis. Med J Chin People’s Health 26:40–1.
   Google Scholar
• Jerdi MC, Daali Y, Oestreicher MK, et al. (2004). A simplified analytical method for a phenotyping cocktail of major CYP450 biotransformation routes. J Pharm Biomed Anal 35:1203–12.
   PubMed Web of Science ®Google Scholar
• Johnson BM, Song IH, Adkison KK, et al. (2006). Evaluation of the drug interaction potential of aplaviroc, a novel human immunodeficiency virus entry inhibitor, using a modified cooperstown 5 + 1 cocktail. J Clin Pharmacol 46:577–87.
   PubMed Web of Science ®Google Scholar
• Kennedy DA, Seely D. (2010). Clinically based evidence of drug-herb interactions: a systematic review. Expert Opin Drug Saf 9:79–124.
   PubMed Web of Science ®Google Scholar
• Lammers LA, Achterbergh R, van Schaik RHN, et al. (2017). Effect of short-term fasting on systemic cytochrome P450-mediated drug metabolism in healthy subjects: a randomized, controlled, crossover study using a cocktail approach. Clin Pharmacokinet 56:1231–44.
   PubMed Web of Science ®Google Scholar
• Li W, Zhao L, Le J, et al. (2015). Evaluation of tetrahydropalmatine enantiomers on the activity of five cytochrome P450 isozymes in rats using a liquid chromatography/mass spectrometric method and a cocktail approach. Chirality 27:551–6.
   PubMed Web of Science ®Google Scholar
• Li Z, Wang G, Zhou HH. (2008). Advances in study of CYP2C9 gene polymorphisms and its functional significances. Chin J Clin Pharmacol Ther 13:601–9.
   Google Scholar
• Liao G, Wang J, Feng XW. (2015). Effects of shuanghuanglian injection combined with ribavirin on acute upper respiratory tract infection. J Bethune Med J 13:415–6.
   Google Scholar
• Nebert DW, Russell DW. (2002). Clinical importance of the cytochromes P450. Lancet Oncol 360:1155–62.
   Web of Science ®Google Scholar
• Rettie AE, Jones JP. (2005). Clinical and toxicological relevance of CYP2C9: drug-drug interactions and pharmacogenetics. Annu Rev Pharmacol Toxicol 45:477–94.
   PubMed Web of Science ®Google Scholar
• Sharma A, Pilote S, Bélanger PM, et al. (2004). A convenient five-drug cocktail for the assessment of major drug metabolizing enzymes: a pilot study. Br J Clin Pharmacol 58:288–97.
   PubMed Web of Science ®Google Scholar
• Siu YA, Lai WG. (2017). Impact of probe substrate selection on cytochrome P450 reaction phenotyping using relative activity factor. Drug Metab Dispos 45:183–9.
   PubMed Web of Science ®Google Scholar
• Song K, Li CL, He F. (2012). Clinical study of Shanghuanglian Powder Injection combined with Amiodarone on serious ventricular arrhythmia induced by aconitine poisoning. China Med Herald 9:97–8.
   Google Scholar
• Wang L, Cheng L, Yuan Q, et al. (2010). Adverse drug reactions of Shuanghuanglian injection: a systematic review of public literatures. J Evid Based Med 3:18–26.
   PubMedGoogle Scholar
• Wang S, Tang X, Yang T, et al. (2018). Predicted contributions of cytochrome P450s to drug metabolism in human liver microsomes using relative activity factor were dependent on probes. Xenobiotica 8:1–8.
   Google Scholar
• Wei CY, Wu FB, Xu T. (2014). CYP450 and Drug Interactions. China Pharm 23:17–20.
   Google Scholar
• Wijnen PA, Op den Buijsch RA, Drent M, et al. (2007). Review article: the prevalence and clinical relevance of cytochrome P450 polymorphisms. Aliment Pharmacol Ther 26:211–9.
   PubMed Web of Science ®Google Scholar
• Wohlfarth A, Naue J, Lutz-Bonengel S, et al. (2012). Cocktail approach for in vivo phenotyping of 5 major CYP450 isoenzymes: development of an effective sampling, extraction, and analytical procedure and pilot study with comparative genotyping. J Clin Pharmacol 52:1200–14.
   PubMed Web of Science ®Google Scholar
• Wu J, Yang S, Zhang D, et al. (2017). Meta-analysis on the randomized controlled trials of Shuanghuanglian Injection in treatment infantile pneumonia. Chin J Pharmacoepidemiol 26:177–82.
   Google Scholar
• Wu Y, Ren JT, Yan M, et al. (2004). Investigation of the clinical situation of Shaunghuanglian injection in six cities during 2001–2002. Chin J Pharmacovigilance 1:21–3.
   Google Scholar
• Xia CH, Sun JG, Wang GJ, et al. (2010). Herb-drug interactions: in vivo and in vitro effect of Shenmai injection, a herbal preparation, on the metabolic activities of hepatic cytochrome P450 3A1/2, 2C6, 1A2, and 2E1 in rats. Planta Med 76:245–50.
   PubMed Web of Science ®Google Scholar
• Yuan HC, Wang DJ, Qiu XJ, et al. (2016). Research progress of interaction between traditional Chinese medicine and drugs. Chin J Clin Pharmacol 32:2332–6.
   Google Scholar
• Yuan HW. (2007). Shuanghuanglian injection of pharmacological action and clinical new uses. Mod Med Health 23:2505–6.
   Google Scholar
• Zhang CB, Zhang Y. (2017). Ceftriaxone sodiumand ribavirin combine with Shuanghuanglian injection may lead to one death. Herald Med 36:833–4.
   Google Scholar